Sales/Maturities of Investments

$0.00

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$0.00period endingJun 30, 2026

MYGN Sales/Maturities of Investments ($569.60M → $0.00)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

MYGN sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	0
Dec 31, 2024	9,000,000
Dec 31, 2023	105,200,000
Dec 31, 2022	128,200,000
Dec 31, 2021	61,100,000
Dec 31, 2020	0
Jun 30, 2020	69,000,000
Jun 30, 2019	79,200,000
Jun 30, 2018	77,700,000
Jun 30, 2017	163,400,000
Jun 30, 2016	115,100,000
Jun 30, 2015	165,600,000
Jun 30, 2014	382,500,000
Jun 30, 2013	385,300,000
Jun 30, 2012	385,236,000
Jun 30, 2011	456,072,000
Jun 30, 2010	408,585,000
Jun 30, 2009	0
Jun 30, 2008	174,420,000
Jun 30, 2007	162,480,000
Jun 30, 2006	100,470,000
Jun 30, 2005	70,956,000
Jun 30, 2004	25,487,000
Jun 30, 2003	50,707,000
Jun 30, 2002	137,181,371
Jun 30, 2001	172,205,932
Jun 30, 2000	25,000,541
Jun 30, 1999	300,200,000
Jun 30, 1998	841,100,000
Jun 30, 1997	592,200,000
Jun 30, 1996	569,600,000